European Imaging Biomarkers Alliance - EIBALL
Subcommittee
EIBALL chair
Prof. Aad Van der Lugt (NL)
EIBALL ex officio member - ResComm chair
Prof. Marion Smits (NL)
EIBALL co-opted member with specific expertise on education
Prof. Laure Fournier (FR)
EIBALL co-opted member with specific expertise on segmentation standardisation project
Prof. Nandita deSouza (UK)
EIBALL co-opted member with specific expertise on QIBA ASL Profile
Prof. Xavier Golay (UK)
EIBALL co-opted member - cross-representation eHealth and Informatics SC
Prof. Elmar Kotter (DE)
EIBALL co-opted member with specific expertise (ESHI-MT representative)
Prof. Olivier Clément (FR)
EIBALL co-opted member with specific expertise (EIBIR rep)
Prof. Anders Persson (SE)
EIBALL co-opted member with specific expertise (ESMRMB rep)
Prof. Edwin Oei (NL)
EIBALL co-opted member with specific expertise (RSNA QIBA rep)
Dr. Gudrun Zahlmann (DE)
EIBALL member
Prof. Nathalie Lassau (FR)
Dr. Lena Costaridou (GR)
Prof. Karen Rosendahl (NO)
Dr. Pim de Graaf (NL)
Prof. Sergios Gatidis (DE)
Prof. Steven Sourbron (UK)
Dr. Wolfgang Kunz (DE)
Dr. Patrick Omouni (CH)
Dr. Philipp Lohmann (DE)
Dr. Maria Bali (BE)
Dr. Caroline Caramella (FR)
Ms. Claire Steinville (FR)
The activities of the former ESR Subcommittee on Imaging Biomarkers, ESR Working Group on Personalised Medicine and ESR-EORTC Working Group were merged into EIBALL.
- Coordinate all ESR activities concerning imaging biomarkers
- Prepare an inventory of all activities and projects in the field of imaging biomarkers where the ESR is involved
- Serve as a tool box that provides information about current projects, centres involved in clinical trials and educational activities
- Define possible imaging biomarkers in different human body regions; oncologic as well as non-oncologic
- Establish a functional biomarker profile that is current and relevant through the development of an online inventory of biomarkers
- Enable and encourage the clinical use of biomarkers by setting standards for data acquisition and image processing
- Closely collaborate with EIBIR to maintain an updated list of European centres of excellence (core institutions) for the implementation and clinical validation of imaging biomarkers
- Closely collaborate with the EORTC (European Organisation for Research and Treatment of Cancer) and its Imaging Group with regard to the inclusion of radiologists in multicentre trials and the development of a biomarker inventory
- Closely collaborate with QIBA (technical validation synergies) to avoid duplication of development and EORTC (biological validation) to coordinate strategies, find complementarity, and benefit from synergies